N-Power Medicine completed the acquisition of Syapse.

N-Power Medicine, a company focused on transforming oncology drug development, completed the acquisition of Syapse, a medicine company. Financial terms were not disclosed. “The integration of Syapse into N-Power underscores our commitment to dramatically accelerating drug development and improving the probability of success by seamlessly integrating clinical research into every oncologist’s practice and every cancer patient’s care. With this scale, N-Power accelerates the transformation of drug development that our pharma customers are asking for - enabling local access to clinical trials for more community oncologists and community cancer patients than ever before, and by creating a unique platform for generating prospective external controls, reducing the need for randomized trials," Mark Lee, N-Power Medicine Co-Founder and Chief Executive Officer.